Decoy Therapeutics Statistics

Total Valuation

DCOY has a market cap or net worth of $5.26 million. The enterprise value is $425,345.

Market Cap	5.26M
Enterprise Value	425,345

Important Dates

The next estimated earnings date is Monday, March 23, 2026, before market open.

Earnings Date	Mar 23, 2026
Ex-Dividend Date	n/a

Share Statistics

DCOY has 6.38 million shares outstanding. The number of shares has increased by 267.48% in one year.

Current Share Class	6.38M
Shares Outstanding	6.38M
Shares Change (YoY)	+267.48%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	4.81%
Float	6.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.19
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.28

Current Ratio	3.28
Quick Ratio	2.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -139.55% and return on invested capital (ROIC) is -92.78%.

Return on Equity (ROE)	-139.55%
Return on Assets (ROA)	-69.91%
Return on Invested Capital (ROIC)	-92.78%
Return on Capital Employed (ROCE)	-131.07%
Weighted Average Cost of Capital (WACC)	6.03%
Revenue Per Employee	n/a
Profits Per Employee	-$2.50M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.66% in the last 52 weeks. The beta is 0.32, so DCOY's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-97.66%
50-Day Moving Average	0.80
200-Day Moving Average	6.43
Relative Strength Index (RSI)	50.24
Average Volume (20 Days)	6,387,403

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-5.57M
Pretax Income	-5.00M
Net Income	-5.00M
EBITDA	-5.56M
EBIT	-5.57M
Earnings Per Share (EPS)	-$33.53

Full Income Statement

Balance Sheet

The company has $4.81 million in cash and n/a in debt, with a net cash position of $4.81 million or $0.75 per share.

Cash & Cash Equivalents	4.81M
Total Debt	n/a
Net Cash	4.81M
Net Cash Per Share	$0.75
Equity (Book Value)	4.25M
Book Value Per Share	4.50
Working Capital	4.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.43M
Capital Expenditures	n/a
Free Cash Flow	-4.43M
FCF Per Share	-$0.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DCOY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-267.48%
Shareholder Yield	-267.48%
Earnings Yield	-95.60%
FCF Yield	-84.68%

Analyst Forecast

The average price target for DCOY is $2.50, which is 203.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.50
Price Target Difference	203.69%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 18, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 18, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1